Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neil Cashman Insider Profile
4 Followers
Neil Cashman, Chief Scientific Officer at ProMIS Neurosci, holds 5.82M shares in ProMIS Neurosci (Ticker: TSE:PMN). Most recently, Neil Cashman Bought C$500,000 shares of ProMIS Neurosci on Dec 31, 2019 for an estimated value of 100.00K.
Neil Cashman ProMIS Neurosci (PMN)Chief Scientific Officer
ProMIS Neurosci (PMN)
Chief Scientific Officer
Ranked #9,028 out of 78,624 Corporate Insiders
Profitable Transactions
5 out of 6 Profitable Transactions
Average Return
+27.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Scientific Officer
Roles that Neil Cashman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Neil Cashman
Neil Cashman's Trading History
List of latest transactions for each holding click on a transaction to see Neil Cashman's performance on stock
You May Also Like
Neil Cashman insider profile FAQ
What is the percentage of profitable transactions made by Neil Cashman?
The percentage of profitable transactions made by Neil Cashman is 83%.
What is the average return per transaction made by Neil Cashman?
The average return per transaction made by Neil Cashman is 27.60%.
What stocks does Neil Cashman hold?
Neil Cashman holds: TSE:PMN stocks.
What was Neil Cashman’s latest transaction?
Neil Cashman latest transaction was an Informative Buy of C$100.00K.
What was Neil Cashman's most profitable transaction?
Neil Cashman’s most profitable transaction was an Informative Sell of TSE:PMN stock on September 29, 2009. The return on the trade was 71.90%.
What is Neil Cashman's role in ProMIS Neurosci?
Neil Cashman's role in ProMIS Neurosci is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.